These include: (A) the knockdown or overexpression of Grx2 in cells, and combination with drug treatment; (B) the relationship between PCNA and Grx2 (which is upregulated and which is downregulated) in cancer cells; and (C) investigating the functional significance of Grx2 in serum. The gene discussed is PCNA; the disease is cancer.